Observational studyMedicine2014

Chromogranin A as a marker for diagnosis, treatment, and survival in patients with gastroenteropancreatic neuroendocrine neoplasm.

Yu-Hong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.